ArticleAIDS research and therapy2026
Determinants of immune recovery and survival in HIV late presenters: a retrospective cohort study from Southwest China.
Article in AIDS research and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundLate presentation (LP) of HIV infection, defined as diagnosis at an advanced stage with a low CD4⁺ T cell count or the presence of AIDS-defining illnesses, remains a major global challenge. Late presenters often experience higher morbidity, poorer immune recovery, and increased mortality, highlighting the importance of early diagnosis and timely initiation of antiretroviral therapy (ART).
methodsA retrospective analysis was conducted among HIV-infected patients who initiated ART at Yunnan Provincial Infectious Disease Hospital between 2004 and 2024. Late presenters were defined as patients with a baseline CD4⁺ T cell count < 350/µL or the presence of AIDS-defining illnesses, regardless of CD4⁺ T cell count. Clinical data were collected, survival rates were analyzed using the Kaplan–Meier method, and Cox regression and logistic regression were applied to identify associated factors.
resultsA total of 7,549 patients were included, with a median follow-up time of 10.0 years (IQR 5.7–13.6). Among them, 73.3% were late presenters. Compared with non-late presenters, late presenters had a higher risk of mortality and poorer immune recovery. Key factors influencing immune recovery included sex, baseline CD4⁺ T cell count, and baseline viral load, with baseline CD4⁺ T cell count being particularly important.
conclusionLate presentation of HIV infection significantly affects survival and immune reconstitution. This study highlights the importance of early diagnosis and intervention and provides evidence for identifying high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.